Eli Lilly 2004 Annual Report Download - page 60

Download and view the complete annual report

Please find page 60 of the 2004 Eli Lilly annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 100

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100

PROXY STATEMENT
5858
Board of Directors
Directors’ Biographies
Class of 2005
The following four directors’ terms will expire at this years annual meeting. Each of these directors has been
nominated and is standing for election to serve another term that will expire in 2008. See page 79 of this proxy
statement for more information.
George M.C. Fisher
Retired Chairman of the Board and Chief Executive Of cer, Eastman Kodak
Company
Director since 2000 Age 64
Mr. Fisher served as chairman of the board of Eastman Kodak Company from 1993
to December 2000. He also served as chief executive of cer from 1993 to Janu-
ary 2000 and as president from 1993 until 1996. Prior to joining Kodak, he was an
executive of cer of Motorola, Inc., serving as chairman and chief executive of cer
from 1990 to October 1993, and president and chief executive of cer from 1988 to
1990. Mr. Fisher is chairman of PanAmSat Corporation, a senior advisor for Kohl-
berg Kravis Roberts & Company, and a director of General Motors Corporation. He
is a member of The Business Council and was chairman of the National Academy of
Engineering from 2000 to 2004.
Alfred G. Gilman, M.D., Ph.D.
Regental Professor and Chairman, Department of Pharmacology, The University
of Texas Southwestern Medical Center
Interim Dean, Southwestern Medical School
Director since 1995 Age 63
Dr. Gilman has served as professor and chairman of the Department of Pharmacol-
ogy at The University of Texas Southwestern Medical Center since 1981 and interim
dean of Southwestern Medical School since 2004. He holds the Raymond and Ellen
Willie Distinguished Chair in Molecular Neuropharmacology, the Nadine and Tom
Craddick Distinguished Chair in Medical Science, and the Atticus James Gill, M.D.
Chair in Medical Science at the university and was named a regental professor in
1995. Dr. Gilman was on the faculty of the University of Virginia School of Medicine
from 1971 until 1981 and was named a professor of pharmacology there in 1977. He
is a director of Regeneron Pharmaceuticals, Inc. Dr. Gilman was a recipient of the
Nobel Prize in Physiology or Medicine in 1994.
Karen N. Horn, Ph.D.
Retired President, Private Client Services, and Managing Director, Marsh, Inc.
Director since 1987 Age 61
Ms. Horn served as president, Private Client Services, and managing director of
Marsh, Inc., a subsidiary of MMC, from 1999 until her retirement in 2003. Prior to
joining Marsh, she was senior managing director and head of international private
banking at Bankers Trust Company; chairman and chief executive of cer, Bank One,
Cleveland, N.A.; president of the Federal Reserve Bank of Cleveland; treasurer of
Bell of Pennsylvania; and vice president of First National Bank of Boston. Ms. Horn
serves as director of T. Rowe Price Mutual Funds; The U.S. Russia Investment Fund,
a presidential appointment; Simon Property Group; and Georgia-Pacifi c Corpora-
tion. Ms. Horn has been senior managing director, Brock Capital Group since 2004.